HGB-207: A Phase 3 Single Arm Study Evaluating the Efficacy and Safety of Gene Therapy in Subjects with Transfusion-dependent B-Thalassemia, who do not have ?0/?0 Genotype, by Transplantation of Autologous CD34+ Stem Cells Tran

Project: Research project

Project Details

StatusFinished
Effective start/end date6/1/166/22/19

Funding

  • Bluebird Bio, Inc.